Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma

被引:58
作者
Boorjian, S [1 ]
Ng, C [1 ]
Munver, R [1 ]
Palese, MA [1 ]
Vaughan, ED [1 ]
Sosa, RE [1 ]
Del Pizzo, JJ [1 ]
Scherr, DS [1 ]
机构
[1] New York Presbyterian Hosp Weill Cornell Med Ctr, Dept Urol, New York, NY 10021 USA
关键词
D O I
10.1016/j.urology.2005.02.022
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate whether a delay in nephroureterectomy for patients with transitional cell carcinoma of the upper urinary tract owing to ureteroscopic biopsy and/or laser tumor ablation affects postoperative disease status. Methods. Of 155 patients diagnosed with upper tract transitional cell carcinoma at our institution from 1993 to 2003, 121 underwent nephroureterectomy. We compared the postoperative disease status of patients who underwent nephroureterectomy on the basis of positive cytology findings and filling defect on contrast imaging (no ureteroscopy; n = 34) to patients who underwent nephroureterectomy after ureteroscopic biopsy (n = 75) and patients who underwent nephroureterectomy after ureteroscopic biopsy and laser tumor ablation (n = 12). Results. At a mean follow-up of 38.7 months, 29 (85.3%) of 34 patients who underwent nephroureterectomy on the basis of contrast imaging and urinary cytology alone were disease free compared with 61 (81.3%) of 75 patients who underwent ureteroscopic biopsy before nephroureterectomy (P = 0.18). The mean time from biopsy to nephroureterectomy for these 75 patients was 28 days, and the mean follow-up after nephroureterectomy was 40.1 months. Finally, 10 (83.3%) of 12 patients who underwent ureteroscopic biopsy and laser tumor ablation before nephroureterectomy were disease free at a mean follow-up of 37.2 months. The mean time from ureteroscopic biopsy to nephroureterectomy in this group was 196 days. No significant difference was found in the postoperative disease status between patients undergoing nephroureterectomy after ablation and those who proceeded to nephroureterectomy after endoscopic biopsy or those who did not undergo ureteroscopy before nephroureterectomy (P = 0.16). Conclusions. Ureteroscopy with biopsy and/or tumor ablation before nephroureterectomy did not adversely affect the postoperative disease status.
引用
收藏
页码:283 / 287
页数:5
相关论文
共 30 条
  • [1] PRIMARY CARCINOMA OF URETER - A REPORT OF 102 NEW CASES
    BLOOM, NA
    [J]. JOURNAL OF UROLOGY, 1970, 103 (05) : 590 - +
  • [2] IMPACT OF ENDOUROLOGY ON DIAGNOSIS AND MANAGEMENT OF UPPER URINARY-TRACT UROTHELIAL CANCER
    BLUTE, ML
    SEGURA, JW
    PATTERSON, DE
    BENSON, RC
    ZINCKE, H
    [J]. JOURNAL OF UROLOGY, 1989, 141 (06) : 1298 - 1301
  • [3] Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage
    Chang, SS
    Hassan, JM
    Cookson, MS
    Wells, N
    Smith, JA
    [J]. JOURNAL OF UROLOGY, 2003, 170 (04) : 1085 - 1087
  • [4] Surveillance of upper urinary tract transitional cell carcinoma: The role of ureteroscopy, retrograde pyelography, cytology and urinalysis
    Chen, GL
    El-Gabry, EA
    Bagley, DH
    [J]. JOURNAL OF UROLOGY, 2000, 164 (06) : 1901 - 1904
  • [5] Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys
    Chen, GL
    Bagley, DH
    [J]. JOURNAL OF UROLOGY, 2000, 164 (04) : 1173 - 1176
  • [6] Rising incidence of renal cell cancer in the United States
    Chow, WH
    Devesa, SS
    Warren, JL
    Fraumeni, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1628 - 1631
  • [7] Endoscopic management of upper urinary tract transitional cell carcinoma - Long-term experience
    Daneshmand, S
    Quek, ML
    Huffman, JL
    [J]. CANCER, 2003, 98 (01) : 55 - 60
  • [8] Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney
    Elliott, DS
    Segura, JW
    Lightner, D
    Patterson, DE
    Blute, ML
    [J]. UROLOGY, 2001, 58 (02) : 174 - 178
  • [9] Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma
    Elliott, DS
    Blute, ML
    Patterson, DE
    Bergstralh, EJ
    Segura, JW
    [J]. UROLOGY, 1996, 47 (06) : 819 - 825
  • [10] The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
    Epstein, JI
    Amin, MB
    Reuter, VR
    Mostofi, FK
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) : 1435 - 1448